key: cord-0875467-7kdzayie
authors: Pradeep Rokkam, Venkata Ram; Kotagiri, Rajesh; Kutti sridharan, Gurusaravanan; Vegunta, Radhakrishna; Prudhvi, Kalyan; Vegunta, Rathnamitreyee; Boregowda, Umesha
title: “Weighing” the risks and benefits – Thromboprophylaxis challenges in obese COVID-19 patients
date: 2020-07-29
journal: Obes Med
DOI: 10.1016/j.obmed.2020.100284
sha: 4f55940f6245a8790cdc8a1f0f9607aa0e1ee934
doc_id: 875467
cord_uid: 7kdzayie

nan

admitted to intensive care unit were noted to be obese in several studies (4-7). Also, hospitalized morbidly obese patients less than 50 years of age with BMI > 40 are more likely to die from COVID 19. (5) Obesity and associated conditions such as hypertension, cardiovascular disease and diabetes were amongst the most common comorbidities in a sample of 2269 deceased COVID-19 patients. (8) Coagulopathy is a common finding in severe COVID 19 patients and both arterial and venous thromboembolic complications have been reported in many studies. (9) Two recent autopsy studies shed light on the link between hypercoagulability and mortality in COVID 19 patients. (10, 11) One study involving [11] [12] [13] [14] [15] [16] [17] [18] [19] patients in which 10 received pharmacological Venous thromboembolism (VTE)

prophylaxis, reported thrombosis mainly in small to mid-sized pulmonary vessels, assumed to be the immediate cause of death, through acute pulmonary hypertension and cessation of pulmonary circulation (10) . In another, VTE was found to be frequent (58%) and pulmonary embolism was reported as the direct cause of death in 4 out of 12 patients (33%) in the series, and all four patients were obese and had a BMI of 34 or above. (11) Interestingly, VTE was not suspected antemortem in any of these patients in both these studies. (10, 11) Obese individuals in general are at higher risk of developing provoked and 

Obesity and impaired metabolic health in patients with COVID-19

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50

Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in

Deaths: A Missed Opportunity and the Lockdown of Science

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity

A multicenter consensus: A role of Furin in the endothelial tropism in obese patients with COVID-19 infection

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

COVID-19 and its implications for thrombosis and anticoagulation

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

"Weighing" the risks and benefits -Thromboprophylaxis challenges in obese

The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Author names: